Search

Felix Lopez Phones & Addresses

  • San Jose, CA

Professional Records

Lawyers & Attorneys

Felix Lopez Photo 1

Felix Lopez - Lawyer

View page
Office:
DiBello & Lopez, P.A.
Specialties:
Commercial Litigation
Securities Litigation
Arbitration
Bankruptcy Litigation
ISLN:
905363903
Admitted:
1989
University:
University of Notre Dame, B.B.A., 1986; University of Notre Dame, B.B.A., 1986; University of Notre Dame, B.B.A., 1986
Law School:
Columbia University School of Law, J.D., 1989
Felix Lopez Photo 2

Felix Lopez - Lawyer

View page
Specialties:
AIDS Law
Family Law
Immigration and Nationality
ISLN:
900487710
Admitted:
1992
University:
University of Michigan, B.G.S., 1974
Law School:
Yale University, J.D., 1991

License Records

Felix M Lopez

License #:
75230 - Expired
Category:
Engineers
Issued Date:
Nov 15, 2012
Effective Date:
Mar 14, 2017
Expiration Date:
Feb 28, 2017
Type:
Professional Engineer

Medicine Doctors

Felix Lopez Photo 3

Felix I. Lopez

View page
Specialties:
General Practice, Neurology
Work:
Orlando Family Physicians
829 Douglas Ave, Altamonte Springs, FL 32714
(407) 332-0003 (phone), (321) 295-7928 (fax)
Education:
Medical School
Inst Sup De Cien Med De Villa Clara, Villa Clara, Cuba
Graduated: 1994
Languages:
English
Spanish
Description:
Dr. Lopez graduated from the Inst Sup De Cien Med De Villa Clara, Villa Clara, Cuba in 1994. He works in Altamonte Springs, FL and specializes in General Practice and Neurology.

Resumes

Resumes

Felix Lopez Photo 4

Felix Lopez St. Louis, MO

View page
Work:
National Geospatial-Intelligence Agency

2010 to 2011
Currently volunteering

Education:
Arizona State University at Tempe
2000 to 2009
geology

University of Puerto Rico at Mayaguez
Mayagez, PR
B.S. in geology

Business Records

Name / Title
Company / Classification
Phones & Addresses
Felix Lopez
Director
FAITH OF HANDS FOUNDATION

Publications

Isbn (Books And Publications)

Cuentos Modernistas

View page
Author

Felix Navas Lopez

ISBN #

8497401182

Reflexiones Y Problemas Practicos Inmobiliarios

View page
Author

Felix Rodriguez Lopez

ISBN #

8485808126

Jurisprudencia Registral Resumida, 1986-1990

View page
Author

Felix Rodriguez Lopez

ISBN #

8487262252

Personnel Interviewing: Theory and Practice

View page
Author

Felix M. Lopez

ISBN #

0070387265

The Making of a Manager: Guidelines to His Selection and Promotion

View page
Author

Felix M. Lopez

ISBN #

0814452205

La Nueva Buena: Ocurrencias Marginales Al Evangelio De Mateo (Perdona Mateo)

View page
Author

Felix Lopez

ISBN #

8430104526

Escritos De Biblia Y Oriente: Miscelanea Conmemorativa Del 25p0s Aniversario Del Instituto Espanol Biblico Y Arqueologico (Casa De Santiago) De Jerusalen

View page
Author

Felix Garcia Lopez

ISBN #

8472990826

Carga Mental Y Fatiga Laboral / Mental Load and Labor Fatigue: Teoria Y Evaluacion / Theory and Evaluation

View page
Author

Felix Sanchez Lopez

ISBN #

8436819845

Us Patents

Heterocyclic Compounds And Their Uses

View page
US Patent:
8193199, Jun 5, 2012
Filed:
Mar 24, 2008
Appl. No.:
12/079406
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Jason A. Duquette - Millbrae CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Brian Lucas - San Francisco CA, US
Lawrence R. McGee - Pacifica CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Garwood NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 473/34
A61K 31/52
A61P 35/00
A61P 19/02
A61P 37/06
A61P 19/08
C07D 487/04
C07D 241/40
C07D 241/44
C07D 215/14
C07D 215/26
C07D 215/22
C07D 417/14
C07D 417/04
US Classification:
5142632, 51426322, 544265, 544277, 544278, 544280, 544353, 544354, 544356, 544119, 546119, 546167, 546168, 546173, 546175, 546180
Abstract:
Substituted bicyclic heteroaryls having the structures:.

Heterocyclic Compounds And Their Uses

View page
US Patent:
8586739, Nov 19, 2013
Filed:
May 10, 2012
Appl. No.:
13/468212
Inventors:
Yi Chen - San Jose CA, US
Timothy D. Cushing - Pacifica CA, US
Jason A. Duquette - Millbrae CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Brian S. Lucas - San Francisco CA, US
Lawrence R. McGee - Pacifica CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer L. Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 487/04
C07D 473/34
C07D 241/40
C07D 241/44
C07D 215/14
C07D 215/26
C07D 215/22
C07D 417/14
C07D 417/04
A61K 31/52
A61P 35/00
A61P 19/02
A61P 37/06
A61P 19/08
US Classification:
544280, 5142651, 51426322, 5142632, 544265, 544277, 544278, 544353, 544354, 544356, 544119, 546119, 546167, 546168, 546173, 546175, 546180
Abstract:
Substituted bicyclic heteroaryls having the general structure:.

Heterocyclic Compounds And Their Uses

View page
US Patent:
20120220586, Aug 30, 2012
Filed:
May 10, 2012
Appl. No.:
13/468234
Inventors:
Yi Chen - San Jose CA, US
Timothy D. Cushing - Pacifica CA, US
Jason A. Duquette - Millbrae CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Brian Lucas - San Francisco CA, US
Lawrence R. McGee - Pacifica CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/52
C07D 473/30
C07D 473/38
A61K 31/5377
A61P 19/02
A61P 37/00
A61P 17/06
A61P 29/00
A61P 1/00
A61P 27/02
A61P 13/10
A61P 17/00
A61P 21/04
A61P 7/00
A61P 25/00
A61P 7/06
A61P 37/08
A61P 27/00
A61P 35/00
A61P 19/00
C07D 473/34
US Classification:
5142342, 544277, 51426322, 544276, 514249, 544118, 51425505
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Heterocyclic Compounds And Their Uses

View page
US Patent:
20130267526, Oct 10, 2013
Filed:
Dec 16, 2011
Appl. No.:
13/994332
Inventors:
Yi Chen - San Jose CA, US
Timothy David Cushing - Pacifica CA, US
Benjamin Fisher - San Mateo CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Xiaolin Hao - Foster City CA, US
Youngsook Shin - Emeryville CA, US
Assignee:
Amgen, Inc. - Thousand Oaks
International Classification:
C07D 471/04
C07D 473/00
C07D 403/12
US Classification:
514249, 544328, 514256, 544295, 51426322, 544277
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer

View page
US Patent:
20140011796, Jan 9, 2014
Filed:
Sep 12, 2013
Appl. No.:
14/025688
Inventors:
Ana Gonzalez Buenrostro - San Mateo CA, US
Hilary Plake Beck - San Carlos CA, US
Xiaoqi Chen - Palo Alto CA, US
Richard Victor Connors - Pacifica CA, US
Jeffrey Deignan - San Francisco CA, US
Jason Duquette - Millbrae CA, US
John Eksterwicz - San Francisco CA, US
Benjamin Fisher - San Mateo CA, US
Brian Matthew Fox - Brisbane CA, US
Jiasheng Fu - Foster City CA, US
Zice Fu - Foster City CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Michael William Gribble - San Francisco CA, US
Dann James Gustin - Half Moon Bay CA, US
Julie Anne Heath - Orinda CA, US
Xin Huang - Wellesley MA, US
Xianyun Jiao - Belmont WA, US
Michael Johnson - San Francisco CA, US
Frank Kayser - San Francisco CA, US
David John Kopecky - San Francisco CA, US
Sujen Lai - Burlingame CA, US
Yihong Li - Millbrae CA, US
Zhihong Li - Millbrae CA, US
Jiwen Liu - Foster City CA, US
Jonathan Dante Low - Tarzana CA, US
Brian Stuart Lucas - San Francisco CA, US
Zhihua Ma - Foster City CA, US
Lawrence R. McGee - Pacifica CA, US
Joel McIntosh - Pacifica CA, US
Dustin McMinn - Pacifica CA, US
Julio Cesar Medina - San Carlos CA, US
Jeffrey Thomas Mihalic - San Francisco CA, US
Steven Howard Olson - Millbrae CA, US
Yosup Rew - Foster City CA, US
Philip Marley Roveto - San Francisco CA, US
Daqing Sun - Foster City CA, US
Xiaodong Wang - Millbrae CA, US
Yingcai Wang - Millbrae CA, US
Xuelei Yan - Foster City CA, US
Ming Yu - Foster City CA, US
Jiang Zhu - Palo Alto CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07D 211/76
C07D 417/12
C07D 413/06
C07D 471/10
C07D 409/04
C07D 401/04
C07D 279/02
C07D 491/08
C07D 498/08
C07D 417/14
C07D 491/153
C07D 417/06
C07D 401/06
C07D 405/04
US Classification:
5142102, 546221, 514327, 544130, 5142355, 546208, 514326, 544 582, 5142278, 546209, 514318, 546210, 546 17, 514278, 546213, 544360, 51425312, 5142362, 546188, 514316, 546207, 544329, 514256, 544 3, 5142222, 544105, 544 11, 5142228, 546 90, 514291, 546216, 544336, 51425505, 544332, 514275, 546198, 514321, 5142305
Abstract:
The present invention provides MDM inhibitor compounds of Formula I,

Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer

View page
US Patent:
20190062276, Feb 28, 2019
Filed:
Mar 21, 2018
Appl. No.:
15/927426
Inventors:
- Thousand Oaks CA, US
Ana Gonzalez Buenrostro - San Mateo CA, US
Hilary Plake Beck - Emerald Hills CA, US
Xiaoqi Chen - Palo Alto CA, US
Richard Victor Connors - Scottsdale AZ, US
Jeffrey Deignan - San Francisco CA, US
Jason A. Duquette - Millbrae CA, US
John Eksterowicz - San Francisco CA, US
Benjamin Fisher - San Mateo CA, US
Brian M. Fox - Brisbane CA, US
Jiasheng Fu - Foster City CA, US
Zice Fu - Foster City CA, US
Felix Gonzalez Lopez De Turiso - Cambridge MA, US
Darin J. Gustin - Half Moon Bay CA, US
Julie A. Heath - Chico CA, US
Xin Huang - Wellesley MA, US
XianYun Jiao - Belmont CA, US
Michael G. Johnson - San Francisco CA, US
Frank Kayser - San Francisco CA, US
David John Kopecky - Studio City CA, US
SuJen Lai - Boston MA, US
Yihong Li - Johns Creek GA, US
Zhihong Li - Millbrae CA, US
Jiwen Liu - Foster City CA, US
Jonathan D. Low - Reseda CA, US
Brian S. Lucas - Arlington MA, US
Zhihua Ma - Lexington MA, US
Lawrence R. McGee - Pacifica CA, US
Joel McIntosh - Pacifica CA, US
Dustin L. McMinn - Pacifica CA, US
Julio C. Medina - San Carlos CA, US
Jeffrey Thomas Mihalic - San Francisco CA, US
Steven H. Olson - Millbrae CA, US
Yosup Rew - Foster City CA, US
Philip M. Roveto - Albuquerque NM, US
Daqing Sun - Foster City CA, US
Xiaodong Wang - Johns Creek GA, US
Yingcai Wang - Millbrae CA, US
Xuelei Yan - Foster City CA, US
Ming Yu - Foster City CA, US
Jiang Zhu - Palo Alto CA, US
International Classification:
C07D 211/76
C07D 279/02
C07D 405/12
C07D 405/04
C07D 491/153
C07D 407/04
C07D 401/12
C07D 401/06
C07D 417/06
C07D 413/06
C07D 491/08
C07D 401/04
C07D 471/10
C07D 221/20
C07D 417/14
C07D 498/08
C07D 409/04
C07D 407/06
C07D 417/12
C07D 498/14
C07D 409/12
C07D 498/20
Abstract:
The present invention provides MDM2 inhibitor compounds of Formula I,

Cis-Morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer

View page
US Patent:
20180354918, Dec 13, 2018
Filed:
Jul 30, 2018
Appl. No.:
16/048677
Inventors:
- Thousand Oaks CA, US
Hilary Plake BECK - Emerald Hills CA, US
Michael R. DEGRAFFENREID - San Francisco CA, US
Brian M. FOX - Brisbane CA, US
Felix GONZALEZ LOPEZ DE TURISO - Cambridge MA, US
Lisa D. JULIAN - Frisco CO, US
Frank KAYSER - San Francisco CA, US
Julio C. MEDINA - San Carlos CA, US
Steven H. OLSON - Millbrae CA, US
Yosup REW - Foster City CA, US
Philip M. ROVETO - Albuquerque NM, US
Daqing SUN - Foster City CA, US
Xuelei YAN - Foster City CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07D 265/32
C07D 413/06
C07D 413/04
C07D 279/12
C07D 487/04
Abstract:
The present invention provides MDM2 inhibitor compounds of Formula I, or the pharmaceutically acceptable salts thereof,wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer

View page
US Patent:
20170144971, May 25, 2017
Filed:
Jan 23, 2017
Appl. No.:
15/412804
Inventors:
- Thousand Oaks CA, US
Ana GONZALEZ BUENROSTRO - San Mateo CA, US
Hilary Plake BECK - Emerald Hills CA, US
Xiaoqi CHEN - Palo Alto CA, US
Richard Victor CONNORS - Scottsdale AZ, US
Jeffrey DEIGNAN - San Francisco CA, US
Jason A. DUQUETTE - Millbrae CA, US
John EKSTEROWICZ - San Francisco CA, US
Benjamin FISHER - San Mateo CA, US
Brian M. FOX - Brisbane CA, US
Jiasheng FU - Foster City CA, US
Zice FU - Foster City CA, US
Felix GONZALEZ LOPEZ DE TURISO - Cambridge MA, US
Darin J. GUSTIN - Half Moon Bay CA, US
Julie A. HEATH - Chico CA, US
Xin HUANG - Wellesley MA, US
XianYun JIAO - Belmont CA, US
Michael G. JOHNSON - San Francisco CA, US
Frank KAYSER - San Francisco CA, US
David John KOPECKY - Studio City CA, US
SuJen LAI - Boston MA, US
Yihong LI - Johns Creek GA, US
Zhihong LI - Millbrae CA, US
Jiwen LIU - Foster City CA, US
Jonathan D. LOW - Reseda CA, US
Brian S. LUCAS - Arlington MA, US
Zhihua MA - Lexington MA, US
Lawrence R. MCGEE - Pacifica CA, US
Joel MCINTOSH - Pacifica CA, US
Dustin L. MCMINN - Pacifica CA, US
Julio C. MEDINA - San Carlos CA, US
Jeffrey Thomas MIHALIC - San Francisco CA, US
Steven H. OLSON - Millbrae CA, US
Yosup REW - Foster City CA, US
Phillip M. ROVETO - Albuquerque NM, US
Daqing SUN - Foster City CA, US
Xiaodong WANG - Johns Creek GA, US
Yingcai WANG - Millbrae CA, US
Xuelei YAN - Foster City CA, US
Ming YU - Foster City CA, US
Jiang ZHU - Palo Alto CA, US
Assignee:
AMGEN INC. - Thousand Oaks CA
International Classification:
C07D 211/76
C07D 417/12
C07D 413/06
C07D 471/10
C07D 409/04
C07D 417/06
C07D 405/04
C07D 401/04
C07D 279/02
C07D 401/12
C07D 491/08
C07D 498/08
C07D 409/12
C07D 405/12
C07D 417/14
C07D 498/20
C07D 401/06
Abstract:
The present invention provides MDM2 inhibitor compounds of Formula I,
Felix Lopez from San Jose, CA Get Report